Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Dose Finding and Efficacy Evaluation of DOXIL (Doxorubicin HCL Liposome Injection) in
Combination with Abraxane (Abraxane) in Patients with Metastatic Breast Cancer (MBC) [Phase I
and II]